Unlock the editor’s summary for free
Roula Khalaf, editor of the FT, selects her favorite stories in this weekly newsletter.
The “Salmon-Sperma Facial” has all the characteristics of a beauty treatment. It has a scandalous name. And numerous celebrities, including the Jennifer Aniston of Perma Glowy, have backed it. But can you fulfill your promise to offer a more youthful skin?
Most often known as polynucleotide treatments, the main ingredient of this new “natural” alternative to filling and botox “are small fragments of salmon sperm DNA that have been extracted humanly from cultivated fish,” he explains Dr. Karen Dohertywho directs a clinic at Stoke Newington in London. Already used in medicine to promote wound healing and improve scars, they are now announced as a non -surgical treatment particularly effective for the notoriously complicated eye area, which helps boost collagen and elastin production, reducing inflammation and regenerating the area as a whole. “Polynucleotides offer a more natural approach to how we treat the area of the eyes, since they are a bioestimulator,” says Doherty, “which means that they stimulate the natural cellular processes of the skin that decrease as we age.”
Polynucleotides can be administered through two methods: cannula (a thin tube with a roma tip) or through very thin needles around the eye. They are suitable for most people, unless you are vegan, allergic to fish or have anaphylaxis history. Most skin experts combine them with other treatments, such as Neogen plasmaA technology based on rejuvenation and adjustment energy that uses nitrogen plasma to regenerate the skin. Most protocols involve three treatments spaced with two or three weeks apart, with results achieved around 16 weeks after their first date. Inactivity time is relatively short: although there is a greater risk that hematomas and swelling may occur if one opts for needles (most treatments will be carried out with the use of numbness cream), patients should generally resume activities within 24 to 48 hours. A series of treatments will cost between £ 450 and £ 2,000 depending on the clinic; It is said that the results last between six and nine months.
Facialist and HTSI columnist Adela crownthat works between Los Angeles, London and New York, says that polynucleotide treatments have become incredibly popular among their clients. “With injectables such as Filler and Botox,” says Crown, “the skin is not taught to produce collagen (the glue that strengthens the structure of the skin).” On the contrary, polynucleotides can be particularly effective to preserve and restore that youth brightness. Crown adds: “It is a slower process, but bio -stimulators such as polynucleotides make skin cells work to produce and support these good skin construction blocks.”
The global Polynucleotides injectable market It is expected to grow at an annual growth rate composed of almost 10 percent to more than 179 million in the next five years. Okay, this is not competence for the Dermal filling category, nor will it overcome eye cream marketthat are worth 7.9 billion and £ 6.3 billion respectively by 2032. But, as a relatively new innovation (it originated in South Korea in around 2015) in a consumer market that is seeing a growing demand for non -surgical aesthetic treatments, remains an impressive beginning.
The makeup artist Isamaya Ffrench, a fan of skin care, says that polynucleotides are “the most restorative and regenerative treatment I have tried.” My skin looks more plump, more firm and significantly more hydrated. ” The French aesthetic doctor based in Paris, Dr. Antoni Calmon, says: “Polynucleotides improve the natural skin of the skin beautywithout altering the facial characteristics “.
The Oculoplastic Surgeon with headquarters in London Dr. Elizabeth Hawkes He is a specialist in the eye area. “I have been doing polynucleotides for approximately two and a half years, and they have transformed my practice,” she says. “Before, we were quite limited in options to rejuvenate the area under the eyes from a non -surgical point of view. With polynucleotides, you don’t have to worry about swelling and obstruct the unique lymphatic system of the eye area, so it is a great option. ”
The treatment is not exempt from detractors. In the United States, the FDA has not yet approved polynucleotides, citing lack of studies (it has strict requirements for medication approvals and aesthetic treatments). “While there have been many different studies on polynucleotides, none of them is particularly high quality,” says Dermatologist Dr. Emma Craythorne. “It is an exciting area, and there is definitely a role for them, but for doctors to offer them as judiciously as things like Botox and Filler (which are very well investigated), we need more solid evidence.” And, as Dr. Calmon warns: “Do not expect a miraculous result as they intend on social networks. They offer a subtle improvement over time. “